Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Balchem Corporation
  6. Summary
    BCPC   US0576652004

BALCHEM CORPORATION

(BCPC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/13/2022 01/14/2022 01/18/2022 01/19/2022 01/20/2022 Date
156.83(c) 155.52(c) 149.75(c) 150.68(c) 148.11 Last
48 880 93 890 161 729 106 243 182 101 Volume
-0.96% -0.84% -3.71% +0.62% -1.71% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 785 M - -
Net income 2021 96,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 50,5x
Yield 2021 0,38%
Sales 2022 844 M - -
Net income 2022 113 M - -
Net Debt 2022 - - -
P/E ratio 2022 42,7x
Yield 2022 0,41%
Capitalization 4 796 M 4 796 M -
Capi. / Sales 2021 6,11x
Capi. / Sales 2022 5,68x
Nbr of Employees 1 305
Free-Float -
More Financials
Company
Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition &... 
Read more
Sector
Food Processing
Calendar
03/01Earnings Release
More about the company
Ratings of Balchem Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about BALCHEM CORPORATION
01/18Balchem Corporation Named on Newsweek's 2022 List of America's Most Responsible Compani..
GL
01/11Alithya Group Working with NASDAQ's Balchem for Global Implementation of Microsoft Dyna..
MT
01/11ALITHYA BRIEF : Says Continuiing Global Implementation of Microsoft Dynamics 365 With NASD..
MT
01/11Alithya continues global implementation of microsoft dynamics 365 with balchem
AQ
01/10Groundbreaking Study Reinforces Need for Increased Choline Supplementation During Pregn..
GL
01/10HC Wainwright Adjusts Balchem's Price Target to $170 from $160, Keeps Buy Rating
MT
01/05Balchem Corporation to Present at the CJS Securities 22nd Annual New Ideas for the New ..
GL
01/04Balchem Corporation to Present at the H.C. Wainwright BIOCONNECT Virtual Conference Jan..
AQ
2021BALCHEM CORPORATION : Ex-dividend day for
FA
2021BALCHEM : Announces Dividend - Form 8-K
PU
2021BALCHEM CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021Balchem Corporation Announces Dividend
GL
2021Balchem Corporation Announces Dividend
GL
2021Balchem Corporation Declares Dividend, Payable on January 21, 2022
CI
2021NORTH AMERICAN MORNING BRIEFING : -3-
DJ
More news
News in other languages on BALCHEM CORPORATION
2021Balchem Corporation déclare un dividende, payable le 21 janvier 2022
2021BALCHEM : hausse du bénéfice ajusté et du chiffre d'affaires net au T3
2021Earnings Flash (BCPC) BALCHEM CORPORATION annonce un chiffre d'affaires de 197,9 millio..
2021Balchem annonce une hausse de son bénéfice et de son chiffre d'affaires au deuxième tri..
2021Earnings Flash (BCPC) BALCHEM CORPORATION affiche un chiffre d'affaires de 202,4 millio..
More news
Analyst Recommendations on BALCHEM CORPORATION
More recommendations
Chart BALCHEM CORPORATION
Duration : Period :
Balchem Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BALCHEM CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 148,11 $
Average target price 154,25 $
Spread / Average Target 4,15%
EPS Revisions
Managers and Directors
Theodore L. Harris Chairman, President & Chief Executive Officer
Martin Bengtsson Chief Financial Officer & Treasurer
Michael Sestrick Chief Technology Officer
Jeff McCartney Senior Director-Information Technology
John Y. Televantos Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BALCHEM CORPORATION-10.63%4 879
BY-HEALTH CO., LTD.-4.38%7 016
HERBALIFE NUTRITION LTD.10.87%4 635
THE SIMPLY GOOD FOODS COMPANY-11.79%3 702
MEDIFAST, INC.-3.51%2 339
USANA HEALTH SCIENCES, INC.-2.12%1 922